In recent years, adiponectin has emerged as a key player in oncology research, as numerous studies have highlighted its dysregulation in various malignancies, particularly those associated with obesity [29–33]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.